TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Bella Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.